[HTML] springer.comFull View

[HTML][HTML] Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC cancer, 2006 - Springer
Abstract Background High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …
被引用次数：18 相关文章
[PDF] psu.edu

[PDF][PDF] Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - Citeseer
Abstract Background: High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …

Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - europepmc.org
Background High risk HPVs are causative agents of anogenital cancers. Viral E6 and E7
genes are continuously expressed and are largely responsible for the oncogenic activity of …
[PDF] academia.edu

[PDF][PDF] Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - academia.edu
Abstract Background: High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …
[PDF] researchgate.net

[PDF][PDF] Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - researchgate.net
Abstract Background: High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …

Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding.

R Villanueva, N Morales-Peza… - BMC …, 2006 - search.ebscohost.com
Abstract Background: High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …

Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza… - BMC …, 2006 - pubmed.ncbi.nlm.nih.gov
Background High risk HPVs are causative agents of anogenital cancers. Viral E6 and E7
genes are continuously expressed and are largely responsible for the oncogenic activity of …
[HTML] nih.gov

[HTML][HTML] Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - ncbi.nlm.nih.gov
Background High risk HPVs are causative agents of anogenital cancers. Viral E6 and E7
genes are continuously expressed and are largely responsible for the oncogenic activity of …
[PDF] core.ac.uk

[PDF][PDF] Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC Cancer, 2006 - core.ac.uk
Abstract Background: High risk HPVs are causative agents of anogenital cancers. Viral E6
and E7 genes are continuously expressed and are largely responsible for the oncogenic …

Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding

R Villanueva, N Morales-Peza, I Castelán-Sánchez… - BMC cancer (Online …, 2006 - osti.gov
High risk HPVs are causative agents of anogenital cancers. Viral E6 and E7 genes are
continuously expressed and are largely responsible for the oncogenic activity of these …